• Over 30 years experience in pharmaceutical development and strategic roles including oversight of various functions including pharmacology, toxicology, manufacturing and regulatory affairs
• Key roles in development programs spanning a wide variety of clinical indications
• Lead two imaging programs for vascular and clot imaging while at EPIX Pharmaceuticals. Ablavar, for vascular imaging approved in the US and EU